Amanta Healthcare
AMANTA •NSE

Amanta Healthcare

₹163.56-7.34 (4.29%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
161.22
Today’s high
171.19
52 week low
92.00
52 week high
209.95
Open price
169.19
Previous close
170.90
Live volume
53,586
Lower circuit
130.85
Upper circuit
196.27

Fundamentals

Market Cap
₹661Cr
ROE
7.46%
P/E Ratio(TTM)
45.05
EPS(TTM)
3.78
P/B Ratio
3.00
Dividend Yield
0.00%
Industry P/E
49.87
Book Value
56.71
Debt to Equity
1.11
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
₹69.44Cr
-11.71%
₹3.31Cr
-40.14%
020406080
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+5%
3Y CAGR+3%
Profit growthValue
1Y (TTM)-6%
3Y CAGR+108%

About

Amanta Healthcare Limited manufactures sterile liquid parenterals, employing Blow-Fill-Seal (BFS) technology for various therapeutic categories.;
CEO/MD
Bhavesh Girishbhai Patel
Founded in
1994
NSE symbol
AMANTA
Industry

Shareholding pattern

Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Shareholder details

Mutual Funds Invested (1)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,325.60
-50.50 (2.13%)
L
    H
    18,042.1426.615.35
    PfizerPFIZER
    ₹3,687.80
    -72.00 (1.91%)
    L
      H
      17,202.9823.44.09
      ₹6,364.50
      +65.50 (1.04%)
      L
        H
        15,745.1392.8218.04
        Natco PharmaNATCOPHARM
        ₹782.40
        -5.15 (0.65%)
        L
          H
          15,453.1313.51.47
          Livesquawk •
          Amanta Healthcare's Q1 EBITDA fell to ₹145M from ₹149M YoY. Q1 EBITDA margin declined to 21.1% from 22.8% YoY.
          Livesquawk •
          Amanta Healthcare schedules analyst and investor meeting on July 9 at 5 PM.
          2026
          3
          Nov
          Quarterly Result
          Upcoming
          Release date
          5
          Aug
          Quarterly Result
          Release date
          19
          May
          Annual Result
          Release date
          10
          Feb
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          26
          Sep
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks